CDXS – Codexis, Inc.
CDXS — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
12.22
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
-0.21
EPS Last/This Y
0.13
EPS This/Next Y
-0.01
Price
1.98
Target Price
6.1
Analyst Recom
1.67
Performance Q
21.47
Upside
-1,019.2%
Beta
2.11
Ticker: CDXS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | CDXS | 1.255 | 0.05 | 0.00 | 2413 |
| 2026-03-10 | CDXS | 1.235 | 0.05 | 561.40 | 2422 |
| 2026-03-11 | CDXS | 1.275 | 0.55 | 500.00 | 3581 |
| 2026-03-12 | CDXS | 1.705 | 0.92 | 0.28 | 4446 |
| 2026-03-13 | CDXS | 1.71 | 0.92 | 0.28 | 4446 |
| 2026-03-17 | CDXS | 1.465 | 0.72 | 0.06 | 5299 |
| 2026-03-18 | CDXS | 1.46 | 0.72 | 0.00 | 5296 |
| 2026-03-19 | CDXS | 1.665 | 0.72 | 0.00 | 5310 |
| 2026-03-20 | CDXS | 1.595 | 0.71 | 0.00 | 5322 |
| 2026-03-23 | CDXS | 1.605 | 0.10 | 0.00 | 1401 |
| 2026-03-24 | CDXS | 1.68 | 0.10 | 0.00 | 1405 |
| 2026-03-25 | CDXS | 1.755 | 0.09 | 0.00 | 1615 |
| 2026-03-26 | CDXS | 1.67 | 0.09 | 0.00 | 1620 |
| 2026-03-27 | CDXS | 1.585 | 0.08 | 0.00 | 1646 |
| 2026-03-30 | CDXS | 1.53 | 0.08 | 0.00 | 1646 |
| 2026-03-31 | CDXS | 1.635 | 0.08 | 1.83 | 1647 |
| 2026-04-01 | CDXS | 1.735 | 0.09 | 0.00 | 1663 |
| 2026-04-02 | CDXS | 1.815 | 0.09 | 999.99 | 1697 |
| 2026-04-06 | CDXS | 1.88 | 0.09 | 0.03 | 1698 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | CDXS | 1.25 | 73.1 | - | -0.60 |
| 2026-03-10 | CDXS | 1.23 | 73.1 | - | -0.60 |
| 2026-03-11 | CDXS | 1.28 | 73.1 | - | -0.60 |
| 2026-03-12 | CDXS | 1.70 | 73.1 | - | -0.60 |
| 2026-03-13 | CDXS | 1.61 | 73.1 | - | -0.60 |
| 2026-03-17 | CDXS | 1.47 | - | - | -0.63 |
| 2026-03-18 | CDXS | 1.45 | - | - | -0.63 |
| 2026-03-19 | CDXS | 1.66 | - | - | -0.63 |
| 2026-03-20 | CDXS | 1.60 | 48.0 | - | -0.46 |
| 2026-03-23 | CDXS | 1.61 | 48.0 | - | -0.46 |
| 2026-03-24 | CDXS | 1.68 | 48.0 | - | -0.46 |
| 2026-03-25 | CDXS | 1.75 | 48.0 | - | -0.46 |
| 2026-03-26 | CDXS | 1.67 | 48.0 | - | -0.46 |
| 2026-03-27 | CDXS | 1.59 | 48.0 | - | -0.46 |
| 2026-03-30 | CDXS | 1.53 | 58.0 | - | -0.37 |
| 2026-03-31 | CDXS | 1.64 | 58.0 | - | -0.37 |
| 2026-04-01 | CDXS | 1.74 | 58.0 | - | -0.37 |
| 2026-04-02 | CDXS | 1.82 | 58.0 | - | -0.37 |
| 2026-04-06 | CDXS | 1.88 | 58.0 | - | -0.37 |
| 2026-04-07 | CDXS | 1.98 | 58.0 | - | -0.37 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | CDXS | -33.19 | 5.74 | 8.29 |
| 2026-03-10 | CDXS | -33.19 | 5.74 | 8.29 |
| 2026-03-11 | CDXS | -33.19 | 5.74 | 10.46 |
| 2026-03-12 | CDXS | -33.19 | 5.74 | 10.46 |
| 2026-03-13 | CDXS | -33.19 | 5.74 | 10.46 |
| 2026-03-17 | CDXS | -33.06 | 5.73 | 10.40 |
| 2026-03-18 | CDXS | -33.06 | 5.73 | 10.40 |
| 2026-03-19 | CDXS | -33.06 | 5.73 | 10.40 |
| 2026-03-20 | CDXS | -33.06 | 5.73 | 10.40 |
| 2026-03-23 | CDXS | -33.06 | 6.17 | 10.40 |
| 2026-03-24 | CDXS | -33.06 | 6.17 | 10.40 |
| 2026-03-25 | CDXS | -33.06 | 6.17 | 12.22 |
| 2026-03-26 | CDXS | -33.06 | 6.17 | 12.22 |
| 2026-03-27 | CDXS | -33.06 | 6.17 | 12.22 |
| 2026-03-30 | CDXS | -33.06 | 6.17 | 12.22 |
| 2026-03-31 | CDXS | -33.06 | 6.17 | 12.22 |
| 2026-04-01 | CDXS | -33.06 | 6.17 | 12.22 |
| 2026-04-02 | CDXS | -33.06 | 6.17 | 12.22 |
| 2026-04-06 | CDXS | -33.06 | 6.27 | 12.22 |
| 2026-04-07 | CDXS | -33.06 | 6.27 | 12.22 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.11
Avg. EPS Est. Current Quarter
-0.1
Avg. EPS Est. Next Quarter
-0.1
Insider Transactions
-33.06
Institutional Transactions
6.27
Beta
2.11
Average Sales Estimate Current Quarter
14
Average Sales Estimate Next Quarter
16
Fair Value
Quality Score
39
Growth Score
36
Sentiment Score
50
Actual DrawDown %
95.3
Max Drawdown 5-Year %
-97.7
Target Price
6.1
P/E
Forward P/E
PEG
P/S
2.56
P/B
3.55
P/Free Cash Flow
EPS
-0.52
Average EPS Est. Cur. Y
-0.37
EPS Next Y. (Est.)
-0.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-62.47
Relative Volume
0.88
Return on Equity vs Sector %
-114.5
Return on Equity vs Industry %
-97.9
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.12
EBIT Estimation
◆
CDXS
Healthcare
$1.98
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
69.5
Range 1M
82.1%
Sup Dist
9.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
13.6%
EPS NY
16.7%
52W%
34.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+208.1% upside
Upside
+208.1%
Quality
39
Codexis, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 146
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
CDXS
Latest News
—
Caricamento notizie per CDXS…
stock quote shares CDXS – Codexis, Inc. Stock Price stock today
news today CDXS – Codexis, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CDXS – Codexis, Inc. yahoo finance google finance
stock history CDXS – Codexis, Inc. invest stock market
stock prices CDXS premarket after hours
ticker CDXS fair value insiders trading